维普中文期刊产品整合服务
36篇 您的检索式:作者名="Georgianos"
    题名 作者 年代 出处 被引量
1Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease:A nested case-control study显示文摘AIM: To compare anemia prevalence between matched chronic kidney disease(CKD) patients with and without diabetes mellitus(DM) and to assess factors associated with anemia development.METHODS: This is a nested case-control study of 184 type-2 diabetic and 184 non-diabetic CKD patients from a prospectively assembled database of a Nephrology outpatient clinic, matched for gender, age and estimated glomerular filtration rate(eG FR). Prevalence of anemia(hemoglobin: Men: < 13 g/dL, women: < 12 g/dL and/or use of recombinant erythropoietin) was examined in comparison, in the total population and by CKD Stage. Univariate and multivariate logistic regression analyses were conducted to identify factors associated with anemia.RESULTS: The total prevalence of anemia was higher in diabetics(47.8% vs 33.2%, P = 0.004). Accordingly, prevalence was higher in diabetics in CKD Stage 3(53.5% vs 33.1%, P < 0.001) and particularly in Stage 3a(60.4% vs 26.4%, P < 0.001), whereas it was nonsignificantly higher in Stage 4(61.3% vs 48.4%; P = 0.307). Serum ferritin was higher in diabetics in total and in CKD stages, while serum iron was similar between groups. In multivariate analyses, DM(OR = 2.206, 95%CI: 1.196-4.069), CKD Stages 3a, 3b, 4(Stage 4: OR = 12.169, 95%CI: 3.783-39.147) and serum iron(OR = 0.976, 95%CI: 0.968-0.985 per mg/d L increase) were independently associated with anemia.CONCLUSION: Prevalence of anemia progressively increases with advancing stages of CKD and is higher in diabetic than matched non-diabetic CKD patients and diabetes is independently associated with anemia occurrence. Detection and treatment of anemia in diabetic CKD patients should be performed earlier than non-diabetic counterparts.Charalampos Loutradis Alexandra Skodra Panagiotis Georgianos Panagiota Tolika Dimitris Alexandrou Afroditi Avdelidou Pantelis A Sarafdis 2016World Journal of Nephrology2016,5,4:9
2Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension显示文摘Hatzistavri LS Sarafidis PA Georgianos PI 2009Am J Hypertens2009,22,10:1
3Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized,placebo-controlled study 显示文摘KANAKI A I SARAFIDIS P A 'GEORGIANOS P I 2012J Hum Hypertens2012,26,10:1
4Effect of thiazolidinediones on albuminuria and proteinuria in diabetes:a meta-analysis显示文摘Sarafidis PA Stafylas PC Georgianos PI 0,,:1
5Effects of lowdose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia显示文摘Kanaki AI Sarafidis PA Georgianos PI 2013Am J Hypertens2013,26,5:1
6Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hyper- cholesterolemia显示文摘Kanaki AI Sarafidis PA Georgianos PI 2013Am J Hyperten2013,26,5:1
7Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile 显示文摘Hadjistavri LS Sarafidis PA Georgianos PI Tziolas IM Aroditis CP Hitoglou-Makedou A Zebekakis PE Pikilidou MI Lasaridis AN 2010Medieal Science Monitor: International Medical Journal Of Experimental And Clinical Research2010,16,6:1
8Resistant hyperten- sion its identification and epidemiology显示文摘Sarafidis PA Georgianos P Bakris GL 2013Nat Rev Nephrol2013,9,1:1
9Effect of thiazolidinediones on albuminuria and proteinuria in diabetes:a meta-analysis显示文摘Sarafidis P A Stafylas P C Georgianos P l 2010Am J Kidney Dis2010,55,5:1
10Low - dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia , a double - blind, randomized, placebo - controlled study 显示文摘Kanaki AI Sarafidis PA Georgianos PI et at 2012J Hum Hypertension2012,26,:1
11Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hyper - cholesterolemia 显示文摘Kanaki AI Sarafidis PA Georgianos PI 2013Am J Hypertens2013,26,5:1
12Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis 显示文摘Sarafidis P A Stafylas P C Georgianos P I 2010Am J Kidney Dis2010,55,5:1
13Intractable hypertension--its identification and epidemiology显示文摘Sarafidis PA1 Georgianos P Bakris G L 2013Nat Rev Nephrol2013,9,1:1
14PPAR-gamma agonism for cardiovascular and renal protection显示文摘Sarafidis PA Georgianos PI Lasaridis AN 2011Cardio- vasc Ther2011,29,6:1
15Effects of low-dose atorv- astatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia 显示文摘Kanaki AI Sarafidis PA Georgianos PI 2013Am J Hyper- tens2013,62,5:1
16Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia:a double-blind,randomized,placebo-controlled study显示文摘Kanaki AI Sarafidis PA Georgianos PI 2012J Hum Hypertens2012,26,10:1
17Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile显示文摘Hadjistavri LS Sarafidis PA Georgianos PI 0,,:1
18Effects of low-dose ator- vastatin on arterial stiffness and central aortic pressure augmenta- tion in patients with hypertension and bypercholesterolemia 显示文摘Kanaki A Sarafidis P Georgianos P 2013American journal of hypertension2013,5,:1
19Effect of thiazo- lidinediones on albuminuria and proteinuria in diabetes: a meta-a- nalysis显示文摘Sarafidis P A Stafylas P C Georgianos P I 2010Am J Kidney Dis2010,55,5:1
20Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia : a double-blind, randomized, placebo-con- trolled study显示文摘Kanaki AI Sarafidis PA Georgianos PI 2012J Hum Hypertens2012,26,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费